CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury

American Journal of Pathology

Volumn 172, Issue 4, 2008, Pages 1141-1152

  Li, Guohong ^a,b,c,d   Sanders, John M ^a   Bevard, Melissa H ^a   Sun, ZhiQi ^b   Chumley, James W ^b   Galkina, Elena V ^a,b   Ley, Klaus ^a,b   Sarembock, Ian J ^a,b,d  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d Ohio Heart and Vascular Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; GELATINASE B; PADGEM PROTEIN;

ACUTE CORONARY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; BLOOD VESSEL INJURY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; IN VITRO STUDY; LEUKOCYTE ACTIVATION; MALE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY BURST; RESTENOSIS; THROMBOCYTE ACTIVATION;

EID: 42049091649     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.070633     Document Type: Article

References (63)

1. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998, 391:591-594
2. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P: Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998, 394:200-203
3. Lutgens E, Gorelik L, Daemen MJ, de Muinck ED, Grewal IS, Koteliansky VE, Flavell RA: Requirement for CD154 in the progression of atherosclerosis. Nat Med 1999, 5:1313-1316
4. Lutgens E, Cleutjens KB, Heeneman S, Koteliansky VE, Burkly LC, Daemen MJ: Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc Natl Acad Sci USA 2000, 97:7464-7469
5. Schonbeck U, Sukhova GK, Shimizu K, Mach F, Libby P: Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc Natl Acad Sci USA 2000, 97:7458-7463
6. Phipps RP, Koumas L, Leung E, Reddy SY, Blieden T, Kaufman J: The CD40-CD40 ligand system: a potential therapeutic target in atherosclerosis. Curr Opin Invest Drugs 2001, 2:773-777
7. Garlichs CD, Kozina S, Fateh-Moghadam S, Handschu R, Tomandl B, Stumpf C, Eskafi S, Raaz D, Schmeisser A, Yilmaz A, Ludwig J, Neundörfer B, Daniel WG: Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke 2003, 34:1412-1418
8. Kopp CW, Steiner S, Nasel C, Seidinger D, Mlekusch I, Lang W, Bartok A, Ahmadi R, Minar E: Abciximab reduces monocyte tissue factor in carotid angioplasty and stenting. Stroke 2003, 34:2560-2567
9. Garlichs CD, Johm S, Schmeisser Eskafi S, Goppelt-Struebe M, Schmieder R, Daniel WG: Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation 2001, 104:2395-2400
10. Sanguigni V, Pignatelli P, Lenti L, Ferro D, Bellia A, Carnevale R, Tesauro M, Sorge R, Lauro R, Violi F: Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients. Circulation 2005, 111:412-419
11. Cipollone F, Chiarelli F, Davi G, Ferri C, Desideri G, Fazia M, Iezzi A, Santilli F, Pini B, Cuccurullo C, Tumini S, Del Ponte A, Santucci A, Cuccurullo F, Mezzetti A: Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control. Diabetologia 2005, 48:1216-1224
12. Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, Simoons ML (CAPTURE Study Investigators): Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003, 348:1104-1111
13. Cipollone F, Ferri C, Desideri G, Paloscia L, Materazzo G, Cuccurullo C, Pini B, Bucci M, Santucci A, Cuccurullo F, Mezzetti A: Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. Circulation 2003, 108:2776-2782
14. Turker S, Guneri S, Akdeniz B, Ozcan MA, Baris N, Badak O, Kirimli O, Yuksel F: Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease. Am J Cardiol 2006, 97:198-202
15. Aggarwal A, Blum A, Schneider DJ, Sobel BE, Dauerman HL: Soluble CD40 ligand is an early initiator of inflammation after coronary intervention. Coron Artery Dis 2004, 15:471-475
16. L'Allier PL, Tardif JC, Gregoire J, Joyal M, Lesperance J, Fortier A, Guertin MC: Sustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosis. Can J Cardiol 2005, 21:495-500
17. Phillips JW, Barringhaus KG, Sanders JM, Yang Z, Chen M, Hesselbacher S, Czarnik AC, Ley K, Nadler J, Sarembock IJ: Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes. Circulation 2003, 108:1994-1999
18. Su Z, Li Y, James JC, Matsumoto AH, Helm GA, Lusis AJ, Shi W: Genetic linkage of hyperglycemia, body weight and serum amyloid-P in an intercross between C57BL/6 and C3H apolipoprotein E-deficient mice. Hum Mol Genet 2006, 15:1650-1658
19. Hansmann G, Wagner RA, Schellong S, Perez VA, Urashima T, Wang L, Sheikh AY, Suen RS, Stewart DJ, Rabinovitch M: Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation 2007, 115:1275-1284
20. Shah PK: Inflammation, neointimal hyperplasia, and restenosis: as the leukocytes roll, the arteries thicken. Circulation 2003, 107:2175-2177
21. Welt FG, Rogers C: Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002, 22:1769-76
22. Weber C, Springer TA: Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor. J Clin Invest 1997, 100:2085-2093
23. Simon DI, Chen Z, Xu H, Li CQ, Dong J, McIntire LV, Ballantyne CM, Zhang L, Furman MI, Berndt MC, Lopez JA: Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/ CD18). J Exp Med 2000, 192:193-204
24. Wang Y, Sakuma M, Chen Z, Ustinov V, Shi C, Croce K, Zago AC, Lopez J, Andre P, Plow E, Simon DI: Leukocyte engagement of platelet glycoprotein Ibalpha via the integrin Mac-1 is critical for the biological response to vascular injury. Circulation 2005, 112:2993-3000
25. Neumann FJ, Ott I, Gawaz M, Puchner G, Schomig A: Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty. J Am Coll Cardiol 1996, 27:819-824
26. Inoue T, Uchida T, Yaguchi I, Sakai Y, Takayanagi K, Morooka S: Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis. Circulation 2003, 107:1757-1763
27. Inoue T, Kato T, Hikichi Y, Hashimoto S, Hirase T, Morooka T, Imoto Y, Takeda Y, Sendo F, Node K: Stent-induced neutrophil activation is associated with an oxidative burst in the inflammatory process, leading to neointimal thickening. Thromb Haemost 2006, 95(1):43-48
28. Inoue T, Sakai Y, Hoshi K, Yaguchi I, Fujito T, Morooka S: Lower expression of neutrophil adhesion molecule indicates less vessel wall injury and might explain lower restenosis rate after cutting balloon angioplasty. Circulation 1998, 97:2511-2518
29. Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Takabatake Y: Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996, 28:1127-1233
30. Li G, Sanders JM, Phan ET, Ley K, Sarembock IJ. Arterial macrophages and regenerating endothelial cells express P-selectin in atherosclerosis-prone apolipoprotein E-deficient mice. Am J Pathol 2005, 167:1511-1518
31. Lindner V, Fingerle J, Reidy MA: Mouse model of arterial injury. Circ Res 1993, 73:792-796
32. Movat H: Demonstration of all connective tissue elements in a single section. Arch Pathol Med 1955, 60:289-295
33. Hay C, Micko C, Prescott MF, Liau G, Robinson K, De Leon H: Differential cell cycle progression patterns of infiltrating leukocytes and resident cells after balloon injury of the rat carotid artery. Arterioscler Thromb Vasc Biol 2001, 21:1948-1954
34. Galkina E, Kadl A, Sanders J, Varughese D, Sarembock IJ, Ley K: Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med 2006, 203:1273-1282
35. Elzey BD, Tian J, Jensen RJ, Swanson AK, Lees JR, Lentz SR, Stein CS, Nieswandt B, Wang Y, Davidson BL, Ratliff TL: Platelet-mediated modulation of adaptive immunity: a communication link between innate and adaptive immune compartments. Immunity 2003, 19:9-19
36. Heinzel FP, Rerko RM, Hujer AM: Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity. Cell Immunol 1998, 184:129-142
37. Li G, Keenan AC, Young J, Fierschnaller V, Berlin H, Hall M, Steinhubl SR, and Smyth SS: Effects of unfractionated heparin and glycoprotein IIb/IIIa antagonists versus bivalirdin on myeloperoxidase release from neutrophils. Arterioscler Thromb Vasc Biol 2007, 27:1850-1856
38. Roque M, Fallon JT, Badimon JJ, Zhang WX, Taubman MB, Reis ED: Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol 2000, 20:335-342
39. Osaka M, Hagita S, Haraguchi M, Kajimura M, Suematsu M, Yoshida M: Real time imaging of mechanically injured-femoral artery in mouse revealed a biphasic pattern of leukocyte accumulation. Am J Physiol Heart Circ Physiol 2007, 292:H1876-H1882
40. Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ: CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003, 92:1041-1048
41. Dole VS, Bergmeier W, Mitchell HA, Eichenberger SC, Wagner DD: Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin. Blood 2005, 106:2334-2339
42. Evangelista V, Pamuklar Z, Piccoli A, Manarini S, Dell'elba G, Pecce R, Martelli N, Federico L, Rojas M, Berton G, Lowell CA, Totani L, Smyth SS: Src family kinases mediate neutrophil adhesion to adherent platelets. Blood 2007, 109:2461-2469
43. Hermann A, Schror K, Weber AA: CD40 ligand (CD40L) does not stimulate proliferation of vascular smooth muscle cells. Eur J Cell Biol 2002, 81:213-221
44. Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD: CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 2002, 8:247-252
45. Zirlik A, Maier C, Gerdes N, MacFarlane L, Soosairajah J, Bavendiek U, Ahrens I, Ernst S, Bassler N, Missiou A, Patko Z, Aikawa M, Schonbeck U, Bode C, Libby P, Peter K. CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation 2007, 27:115:1571-1580
46. Pignatelli P, Sanguigni V, Lenti L, Ferro D, Finocchi A, Rossi P, Violi F: gp91phox-dependent expression of platelet CD40 ligand. Circulation 2004, 110:1326-1329
47. Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, Hong MK, Popma JJ, Leon MB: Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia: a serial intravascular ultrasound study. Circulation 1997, 95:1366-1369
48. Kornowski R, Mintz GS, Abizaid A, Leon MB: Intravascular ultrasound observations of atherosclerotic lesion formation and restenosis in patients with diabetes mellitus. Int J Cardiovasc Intervent 1999, 2:13-20
49. Radke PW, Friese K, Buhr A, Nagel B, Harland LC, Kaiser A, Remmel M, Hanrath P, Schunkert H, Hoffmann R: Comparison of coronary restenosis rates in matched patients with versus without diabetes mellitus. Am J Cardiol 2006, 98:1218-1222
50. Moreno PR, Bernardi VH, Lopez-Cuellar J, Newell JB, McMellon C, Gold HK, Palacios IF, Fuster V, Fallon JT: Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation 1996, 94:3098-3102
51. Wang CY, Mazer SP, Minamoto K, Takuma S, Homma S, Yellin M, Chess L, Fard A, Kalled SL, Oz MC, Pinsky DJ: Suppression of murine cardiac allograft arteriopathy by long-term blockade of CD40-CD154 interactions. Circulation 2002, 105:1609-1614
52. Manka D, Forlow SB, Sanders JM, Hurwitz D, Bennett DK, Green SA, Ley K, Sarembock IJ: Critical role of platelet P-selectin in the response to arterial injury in apolipoprotein-E-deficient mice. Arterioscler Thromb Vasc Biol 2004, 24:1124-1129
53. Schober A, Manka D, von Hundelshausen P, Huo Y, Hanrath P, Sarembock IJ, Ley K, Weber C: Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 2002, 106:1523-1529
54. Simon DI, Dhen Z, Seifert P, Edelman ER, Ballantyne CM, Rogers C: Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty. J Clin Invest 2000, 105:293-300
55. Welt FG, Edelman ER, Simon DI, Rogers C: Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol 2000, 20:2553-2558
56. Rogers C, Welt FG, Karnovsky MJ, Edelman ER: Monocyte recruitment and neointimal hyperplasia in rabbits. Arterioscler Thromb Vasc Biol 1996, 16:1312-1318
57. Inoue T, Uchida T, Sakuma M, Imoto Y, Ozeki Y, Ozaki Y, Hikichi Y, Node K: Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation. J Am Coll Cardiol 2004, 44:1408-1414
58. Chakrabarti S, Varghese S, Vitseva O, Tanriverdi K, Freedman JE: CD40 ligand influences platelet release of reactive oxygen intermediates. Arterioscler Thromb Vasc Biol 2005, 25:2428-2434
59. Ma YQ, Plow EF, Geng JG: P-selectin binding to P-selectin glycoprotein ligand-1 induces an intermediate state of alphaMbeta2 activation and acts cooperatively with extracellular stimuli to support maximal adhesion of human neutrophils. Blood 2004, 104:2549-2556
60. Sanguigni V, Ferro D, Pignatelli P, Del Ben M, Nadia T, Saliola M, Sorge R, Violi F: CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia. J Am Coll Cardiol 2005, 45:35-42
61. Chen Z, Keaney JF Jr., Schulz E, Levison B, Shan L, Sakuma M, Zhang X, Shi C, Hazen SL, Simon DI: Decreased neointimal formation in Nox2-deficient mice reveals a direct role for NADPH oxidase in the response to arterial injury. Proc Natl Acad Sci USA 2004, 101:13014-13019
62. Urbich C, Dernbach E, Aicher A, Zeiher AM, Dimmeler S: CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation 2002, 106:981-986
63. Lee MS, David EM, Makkar RR, Wilentz JR: Molecular and cellular basis of restenosis after percutaneous coronary intervention: the intertwining roles of platelets, leukocytes, and the coagulation-fibrinolysis system. J Pathol 2004, 203:861-870